ALS Limited Budget 2013-14: Group Summary

one

ALS

Life Sciences Commodities

Industrial

Full Year Results FY2016 Investor Presentation 30th May 2016

1

RIGHT SOLUTIONS · RIGHT PARTNER

All figures stated in AUD unless otherwise stated

  • This presentation has been prepared by ALS Limited, (ALS or the Company). It contains general information about the Company's activities as at the date of the presentation. It is information given in summary form and does not purport to be complete. The distribution of this presentation in jurisdictions outside Australia may be restricted by law, and you should observe any such restrictions.

  • This presentation is not, and nothing in it should be construed as, an offer, invitation or recommendation in respect of securities, or an offer, invitation or recommendation to sell, or a solicitation of an offer to buy, securities in any jurisdiction. Neither this document nor anything in it shall form the basis of any contract or commitment. This presentation is not intended to be relied upon as advice to investors or potential investors and does not take into account the investment objectives, financial situation or needs of any investor. All investors should consider such factors in consultation with a professional advisor of their choosing when deciding if an investment is appropriate.

  • The Company has prepared this presentation based on information available to it, including information derived from public sources that have not been independently verified. No representation or warranty, express or implied, is provided in relation to the fairness, accuracy, correctness, completeness or reliability of the information, opinions or conclusions expressed herein.

  • This presentation includes forward-looking statements within the meaning of securities laws. Any forward- looking statements involve known and unknown risks and uncertainties, many of which are outside the control of the Company and its representatives. Forward-looking statements may also be based on estimates and assumptions with respect to future business decisions, which are subject to change. Any statements, assumptions, opinions or conclusions as to future matters may prove to be incorrect, and actual results, performance or achievement may vary materially from any projections and forward-looking statements.

  • Due care and attention should be undertaken when considering and analysing the financial performance of the

    Company.

  • All references to dollars are to Australian currency unless otherwise stated.

    FY2016 Revenue

    Environmental Food

    Pharmaceutical Consumer Products

    Geochemistry Mine Site

    Metallurgy Trade Inspection

    Asset Care Tribology

    Life Sciences

    Minerals

    Industrial

    Energy

    Environmental

    Food

    Pharmaceutical

    Consumer Products

    Geochemistry

    Mine Site

    Metallurgy

    Trade Inspection

    Asset Care

    Tribology

    Coal

    Oil & Gas

    Coal Oil & Gas

    Note: the majority of Mine Site work is geochemistry

    Life Sciences

    Commodities

    Industrial

    •Environmental

    •Food

    •Pharmaceutical

    •Industrial Hygiene

    •Consumer Products

    •Geochemistry

    •Metallurgy

    •Coal

    •Oil & Gas

    •Trade Inspection

    •Asset Care

    •Tribology

    How do our end markets want to interact with ALS?

    "On e ALS " Pr oje ct

  • promoting a broad range of services to an end market

  • packaging services

  • cross business stream ALS portal

  • improve and simplify B2B interaction

  • leveraging clients across business streams

ALS Limited published this content on 30 May 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 30 May 2016 02:50:07 UTC.

Original documenthttp://www.alsglobal.com/~/media/Files/ASX Announcements/2016 05 30 Investor Presentation - FY2016 Results.pdf

Public permalinkhttp://www.publicnow.com/view/CD1DD7CC3CD122DA84B3A63E77BE59E37260BFCD